Abstract:Antimicrobial peptides (AMPs) provide protection against a variety of pathogenic bacteria and are, therefore, an important part of the innate immune system. Over the past decade, there has been considerable interest in developing AMPs as intravenously administered antibiotics. However, despite extensive efforts in the pharmaceutical and biotechnology industry, it has proven difficult to achieve this goal. While researchers have solved some relatively simple problems such as susceptibility to proteolysis, more severe problems have included the expense of the materials, toxicity, poor efficacy, and limited tissue distribution. In this Account, we describe our efforts to design and synthesize "foldamers"-- short sequence-specific oligomers based on arylamide and beta-amino acid backbones, which fold into well-defined secondary structures-- that could act as antimicrobial agents. We reasoned that small "foldamers" would be less expensive to produce than peptides, and might have better tissue distribution. It should be easier to fine-tune the structures and activities of these molecules to minimize toxicity. Because the activities of many AMPs depends primarily on their overall physicochemical properties rather than the fine details of their precise amino acid sequences, we have designed and synthesized very small "coarse-grained" molecules, which are far simpler than naturally produced AMPs. The molecular design of these foldamers epitomizes the positively charged amphiphilic structures believed to be responsible for the activity of AMPs. The designed oligomers show greater activity than the parent peptides. They have also provided leads for novel small molecule therapeutics that show excellent potency in animal models for multidrug resistant bacterial infections. In addition, such molecules can serve as relatively simple experimental systems for investigations aimed at understanding the mechanism of action for this class of antimicrobial agents. The foldamers' specificity for bacterial membranes relative to mammalian membranes appears to arise from differences in membrane composition and physical properties between these cell types. Furthermore, because experimental coarse-graining provided such outstanding results, we developed computational coarse-grained models to enable molecular dynamic simulations of these molecules with phospholipid membranes. These simulations allow investigation of larger systems for longer times than conventional molecular dynamics simulations, allowing us to investigate how physiologically relevant surface concentrations of AMP mimics affect the bilayer structure and properties. Finally, we apply the principles discovered through this work to the design of inexpensive antimicrobial polymers and materials.

Biomimetic Design of Membrane-active Amphiphilic Polymers

An Antimicrobial Peptide-Mimetic Methacrylate Random Copolymer Induces Domain Formation in a Model Bacterial Membrane

Therapeutic design of peptide modulators of protein-protein interactions in membranes

Formation of a planar biomimetic membrane with a novel zwitterionic polymer for nanopore sequencing

Membrane-Mimicking Reverse Micelles for High-Resolution Interfacial Study of Proteins and Membranes

Biomimetic interfaces based on S-layer proteins, lipid membranes and functional biomolecules

Computational design of a minimal "protein-like" conjugate for potent membrane poration

Host defense peptide mimicking antimicrobial amino acid polymers and beyond: design, synthesis and biomedical applications

De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications

Biomembrane surfaces as models for polymer design: the potential for haemocompatibility

Advanced and Designing Strategies in Polymeric Antifungal Agents Inspired by Membrane‐Active Peptides

Polymer membrane and cell models for drug discovery.

Biomimetic Membranes with Transmembrane Proteins: State-of-the-Art in Transmembrane Protein Applications

Physicochemical Features and Peculiarities of Interaction of Antimicrobial Peptides with the Membrane

Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics

Polymersome Membrane Engineering with Active Targeting or Controlled Permeability for Responsive Drug Delivery

Amphiphilicity Is a Key Determinant in the Membrane Interactions of Synthetic 14-mer Cationic Peptide Analogues

Antimicrobial Peptide Mimetics Based on a Diphenylacetylene Scaffold: Synthesis, Conformational Analysis, and Activity

The Role of Negatively Charged Groups in Antimicrobial Cationic Peptide Mimics: Insights into Membrane Interactions

Porous biomimetic membranes: fabrication, properties and future applications.

Unlocking the Specificity of Antimicrobial Peptide Interactions for Membrane-Targeted Therapies